NICOLE MCHENRY: Open Payments
NPI 1558134528 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $208 · 2025 $543
Food & beverage: $444Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $160 |
| Janssen Biotech, Inc. | 4 | $110 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| BeOne Medicines USA, Inc. | 1 | $30 |
| Tempus AI, Inc | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $27 |
| BeiGene USA, Inc. | 1 | $25 |
| Aveo Pharmaceuticals, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
Products named: IMBRUVICA, KEYTRUDA, ERLEADA, CARVYKTI, TEVIMBRA, XT CDX, DATROWAY, BRUKINSA.
Industry payments across NY — which companies pay providers there.
